Camptothecin Nanowires Induce the cGAS-STING Pathway to Remold Tumor-Associated Macrophages for Antitumor Immunity
Pharmaceutics · 25.05.2026 · 18 (6) · 649
DOI: 10.3390/pharmaceutics18060649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 25.05.2026. Verfasst von Congyi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background/Objectives: This study aimed to develop a novel tumor-associated macrophage (TAM)-targeting nanoplatform to improve the solubility and bioavailability of camptothecin (CPT) and achieve active targeted drug delivery for enhanced anti-tumor immunotherapy.
Methods
We constructed a sialic acid-disulfide bond-camptothecin (SA-SS-CPT) nanowire system. Sialic acid was used as a targeting ligand to specifically recognize the overexpressed Siglec-E receptor on TAMs. Upon cellular internalization, the disulfide bond was designed to respond to intracellular glutathione (GSH), enabling controlled drug release.
Results
The SA-SS-CPT nanowires significantly improved CPT solubility and enabled targeted delivery to TAMs. Following GSH-responsive cleavage and CPT release, the nanowires induced DNA damage in TAMs, activating the cGAS-STING signaling pathway. This promoted TAM polarization toward the M1 phenotype, enhanced pro-inflammatory and anti-tumor immune responses, and inhibited tumor immune escape. Furthermore, SA-SS-CPT synergistically improved the efficacy of PD-L1 blockade immunotherapy, remodeling the tumor immune microenvironment.
Conclusions
The SA-SS-CPT nanoplatform effectively targets TAMs, repolarizes them to an anti-tumor M1 phenotype, and activates the cGAS-STING pathway. It shows strong potential for overcoming tumor immune escape and synergizing with PD-L1 checkpoint blockade to achieve significant tumor clearance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatopancreatobiliary Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
- Department of Hepatic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
- Department of Children's and Adolescent Health, Public Health College, Harbin Medical University, Harbin 150086, China.
- Department of Pharmaceutics, Harbin Medical University-Daqing Campus, 1 Xinyang Rd, Daqing 163319, China.
ORCID-Profile: Dixiang Wen, Changmei Zhang
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Zhang, C., Wu, H., Chen, X., Yin, W., Huang, S., Wen, D., Song, X., Xu, X., Zhang, C., & Tai, S. (2026). Camptothecin Nanowires Induce the cGAS-STING Pathway to Remold Tumor-Associated Macrophages for Antitumor Immunity. Pharmaceutics, 18(6), 649. https://doi.org/10.3390/pharmaceutics18060649
Vancouver
Zhang C, Wu H, Chen X, Yin W, Huang S, Wen D, et al. Camptothecin Nanowires Induce the cGAS-STING Pathway to Remold Tumor-Associated Macrophages for Antitumor Immunity. Pharmaceutics. 2026;18(6):649. doi:10.3390/pharmaceutics18060649
BibTeX
@article{Zhang2026,
author = {Zhang, Congyi and Wu, Haotian and Chen, Xiaotong and Yin, Wenze and Huang, Shizhuan and Wen, Dixiang and Song, Xueting and Xu, Xiaoyan and Zhang, Changmei and Tai, Sheng},
title = {Camptothecin Nanowires Induce the cGAS-STING Pathway to Remold Tumor-Associated Macrophages for Antitumor Immunity},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {6},
pages = {649},
doi = {10.3390/pharmaceutics18060649}
}
EUVIMED